Skip to content

V · ZEN.V · MEDICAL - INSTRUMENTS & SUPPLIES

Zentek Ltd. (ZEN.V) intrinsic value and stock valuation

$0.52as of 2026-11-21 · Mkt cap 84.96M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Zentek Ltd. DCF and intrinsic value

InvestorsCraft values ZEN.V with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from ZEN.V’s statements →

Zentek Ltd. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Instruments & Supplies Guelph, ON P7B 6M4 zentek.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$870K
20112025
Net income
-$-10.04M
20112025
Free cash flow
-$-6.28M
20112025
Total equity
$14.8M-10.5% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$870K$30K$70K$340K$0.00
Operating income-$-9.6M-$-11.98M-$-14.15M-$-12.56M-$-3.98M
Net income-$-10.04M-$-11.7M-$-14.41M-$-38.69M-$-3.87M
EPSd-$-97.49K-$-116.42K-$-144.91K-$-420.13K-$-46.06K
Operating cash flow-$-6.28M-$-8.05M-$-12.96M-$-7.99M-$-1.79M
Capital expenditure-$0.00-$-320K-$-2.27M-$-3.99M-$-250K
Free cash flow-$-6.28M-$-8.37M-$-15.23M-$-11.97M-$-2.05M
Total assets$18.4M$22.6M$33.3M$38M$30.3M
Total debt$680K$1.24M$1.61M$2.23M$400K
Net debt$560K-$-2.28M-$-8.75M-$-24.44M-$-2.69M
Total equity$14.8M$20.2M$30.4M$34.6M$27.5M
Cash and short-term investments$120K$3.52M$10.4M$26.7M$3.09M
Income statement
20252024202320222021
Revenue$870K$30K$70K$340K$0.00
Cost of revenue$680K$410K$850K$610K$130K
Gross profit$190K-$-390K-$-780K-$-280K-$-120K
Research and development expenses$470K$1.78M$1.65M$1.54M$0.00
Selling, general and administrative expenses$8.01M$8.95M$10.9M$9.56M$4.2M
Other expenses$1.31M$960K-$0.00$0.00$110K
Operating expenses$9.79M$11.7M$14.7M$12.3M$3.98M
Cost and expenses$10.5M$11M$14.7M$12.3M$3.98M
Interest income$100K$410K$510K$20K$10K
Interest expense$100K$110K$130K$70K$10K
Depreciation and amortization$600K$610K$540K$610K$130K
Ebitda-$-9.35M-$-11.08M-$-13.75M-$-11.27M-$-3.73M
Operating income-$-9.6M-$-11.98M-$-14.15M-$-12.56M-$-3.98M
Total other income/expenses, net-$-440K$170K-$-260K$540K$120K
Income before tax-$-10.04M-$-11.8M-$-14.41M-$-12.02M-$-3.87M
Income tax expense$0.00-$-100K$120K$26.7M-$-10K
Net income-$-10.04M-$-11.7M-$-14.41M-$-38.69M-$-3.87M
Weighted average shares outstanding$103M$97.5M$99.4M$92.1M$84M
Weighted average diluted shares outstanding$103M$100.5M$99.4M$92.1M$84M
Balance sheet
20252024202320222021
Cash and short-term investments$120K$3.52M$10.4M$26.7M$3.09M
Net receivables$1.2M$840K$10K$3.61M$120K
Inventory$890K$1.42M$2.85M$670K$0.00
Total current assets$4.37M$6.25M$18M$32M$3.39M
Property, plant and equipment, net$12.7M$15M$15.3M$6.03M$26.9M
Goodwill and intangible assets$0.00$0.00$0.00$0.00$0.00
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$14M$16.3M$15.3M$6.03M$26.9M
Total assets$18.4M$22.6M$33.3M$38M$30.3M
Accounts payable$2.01M$540K$910K$1.04M$350K
Short-term debt$520K$650K$1.13M$1.1M$120K
Deferred revenue$0.00$0.00$0.00$0.00$30K
Total current liabilities$3.48M$1.82M$2.42M$2.3M$2.51M
Long-term debt$160K$590K$480K$1.13M$280K
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$160K$590K$480K$1.13M$280K
Capital lease obligations$330K$480K$610K$280K$400K
Total liabilities$3.65M$2.41M$2.9M$3.44M$2.79M
Common stock$89.5M$86.1M$85.8M$85.5M$43.8M
Retained earnings-$-83.85M-$-76.62M-$-66.2M-$-59.18M-$-20.49M
Accumulated other comprehensive income (loss)$9.13M$10.7M$10.8M$8.23M$4.15M
Total equity$14.8M$20.2M$30.4M$34.6M$27.5M
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$680K$1.24M$1.61M$2.23M$400K
Net debt$560K-$-2.28M-$-8.75M-$-24.44M-$-2.69M
Cash flow statement
20252024202320222021
Net income-$-10.04M-$-11.7M-$-14.41M-$-12.02M-$-3.87M
Depreciation and amortization$600K$610K$540K$610K$130K
Stock-based compensation$1.53M$1.79M$3.2M$4.73M$2.02M
Change in working capital$1.48M$910K-$-2.4M-$-1.36M$40K
Accounts receivable-$-910K$270K-$-10K-$-540K-$-40K
Inventory$400K-$-70K-$-2.18M-$-670K$0.00
Accounts payable$1.8M$0.00$10K$830K$0.00
Net cash provided by operating activities-$-6.28M-$-8.05M-$-12.96M-$-7.99M-$-1.79M
Investments in property, plant and equipment-$0.00-$-320K-$-2.27M-$-3.99M-$-250K
Acquisitions, net$0.00$10K$0.00$0.00$0.00
Net cash used for investing activities$360K$1.88M-$-2.31M-$-7.25M-$-1.23M
Common stock issued$3.07M$0.00$0.00$35.3M$2.05M
Common stock repurchased$0.00-$-410K$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$2.52M-$-670K-$-1.05M$38.8M$5.31M
Net change in cash-$-3.4M-$-6.84M-$-16.32M$23.6M$2.29M
Cash at end of period$120K$3.52M$10.4M$26.7M$3.09M
Operating cash flow-$-6.28M-$-8.05M-$-12.96M-$-7.99M-$-1.79M
Capital expenditure-$0.00-$-320K-$-2.27M-$-3.99M-$-250K
Free cash flow-$-6.28M-$-8.37M-$-15.23M-$-11.97M-$-2.05M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Zentek Ltd.

        Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.

        CEO
        Mohammed Jiwan
        Employees
        24
        Beta
        0.31

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of Zentek Ltd. (ZEN.V)?

        InvestorsCraft does not currently publish an intrinsic value for ZEN.V. How the IC value is calculated.

        Is ZEN.V undervalued?

        InvestorsCraft does not publish an undervaluation signal for ZEN.V at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.